The new filling and closing machine FXS Combi - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The new filling and closing machine FXS Combi

Depending on output and container, the new filling and closing machine FXS Combi with two or five positions processes pre-sterilized nested syringes, vials and cartridges. The FXS Combi is the first filling and closing machine of this kind with an integrated capping station for vials and cartridges. It can be easily integrated into line concepts, allowing for significant space savings. The FXS Combi is suited for low and medium output rates.

The FXS Combi operates with a combi filling station with up to six dosing heads. This makes the machine suitable for all common filling technologies, such as peristaltic or rotary slide valve piston pumps as well as the single-use filling technology PreVAS. A combination with different barrier systems is also possible; the FXS Combi is suited for both Restricted Access Barrier Systems (RABS) and isolators. By combining the new filling and closing machine with the proven upstream ATO tub opener and ABO bag opener from Bosch, it can be integrated into fully automated line concepts.

Robert Bosch GmbH, Packaging Technology division

Website: www.boschpackaging.com

E-mail: packaging@bosch.com
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
FindPharma Custom Search

Click here